FDA Approves Sensus SRT-100 for Keloids

The FDA has given the nod to Sensus Healthcare (Boca Raton FL) to start the marketing of its SRT-100 superficial radiotherapy system for the treatment of keloids, or scar tissue

The FDA has given the nod to Sensus Healthcare (Boca Raton FL) to start the marketing of its SRT-100 superficial radiotherapy system for the treatment of keloids, or scar tissue which takes shape over a wound after injury or surgical procedures. The system is employed for the treatment of non-melanoma skin cancers.

The SRT-100 employs superficial X-rays to deliver radiation to the surface of the skin and this does not cause any pain. Anesthesia is also not required while using this system.

Survival in Patients With Stage III Lung Cancer Hampered by Higher Dose of Radiotherapy
Compared with standard-dose (SD), high-dose radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer.

“Painful and potentially disfiguring keloid scars are very difficult to effectively treat by surgery or other means due to recurrence rates as high as 45 to 100%. Studies show that the use of adjunctive radiation therapy can dramatically reduce the rate of recurrences,” said Mark S. Nestor , MD, PhD of the Center for Cosmetic Enhancement in Aventura, FL.

SRT-100™ is the perfect treatment method for non-melanoma skin cancers and keloids, with its SharpBeam™ technology. This system ensures that only the targeted lesion is treated and the surrounding and underlying healthy tissue is not touched.

Radiotherapy Remains the Treatment of First Choice for High-Risk Low-Grade Glioma
Researchers compared initial radiotherapy to temozolomide chemotherapy in a large, international, randomized trial.

Source-Medindia

Quality of Life In Elderly Patients Improved By Palliative Radiotherapy for Bone Metastases
A Dutch researcher told the 2nd Forum of the ESTRO, giving palliative radiotherapy to elderly patients with painful bone metastases can significantly improve their quality of life.

In Patients With Early Breast Cancer Intensity Modulated Radiotherapy Reduces Side Effects
According to results, intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer.